NM_001374828.1:c.1185_1193delCGGCGGCGG

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_001374828.1(ARID1B):​c.1185_1193delCGGCGGCGG​(p.Gly396_Gly398del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.00199 in 1,403,448 control chromosomes in the GnomAD database, including 10 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 3 hom., cov: 29)
Exomes 𝑓: 0.0019 ( 7 hom. )

Consequence

ARID1B
NM_001374828.1 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 4.68

Publications

1 publications found
Variant links:
Genes affected
ARID1B (HGNC:18040): (AT-rich interaction domain 1B) This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ARID1B Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina, ClinGen
  • Coffin-Siris syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001374828.1
BP6
Variant 6-156778847-GGGCGGCGGC-G is Benign according to our data. Variant chr6-156778847-GGGCGGCGGC-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 434371.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.00267 (395/147916) while in subpopulation EAS AF = 0.00637 (31/4864). AF 95% confidence interval is 0.00461. There are 3 homozygotes in GnomAd4. There are 213 alleles in the male GnomAd4 subpopulation. Median coverage is 29. This position passed quality control check.
BS2
High AC in GnomAd4 at 395 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID1BNM_001374828.1 linkc.1185_1193delCGGCGGCGG p.Gly396_Gly398del disruptive_inframe_deletion Exon 1 of 20 ENST00000636930.2 NP_001361757.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID1BENST00000636930.2 linkc.1185_1193delCGGCGGCGG p.Gly396_Gly398del disruptive_inframe_deletion Exon 1 of 20 2 NM_001374828.1 ENSP00000490491.2 Q8NFD5-3A0A6Q8NVI4

Frequencies

GnomAD3 genomes
AF:
0.00266
AC:
393
AN:
147812
Hom.:
3
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00343
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00147
Gnomad ASJ
AF:
0.000878
Gnomad EAS
AF:
0.00656
Gnomad SAS
AF:
0.00172
Gnomad FIN
AF:
0.00670
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00176
Gnomad OTH
AF:
0.00343
GnomAD2 exomes
AF:
0.00247
AC:
137
AN:
55508
AF XY:
0.00219
show subpopulations
Gnomad AFR exome
AF:
0.00198
Gnomad AMR exome
AF:
0.00102
Gnomad ASJ exome
AF:
0.000245
Gnomad EAS exome
AF:
0.00797
Gnomad FIN exome
AF:
0.00723
Gnomad NFE exome
AF:
0.00116
Gnomad OTH exome
AF:
0.00155
GnomAD4 exome
AF:
0.00191
AC:
2395
AN:
1255532
Hom.:
7
AF XY:
0.00188
AC XY:
1160
AN XY:
617146
show subpopulations
African (AFR)
AF:
0.00336
AC:
83
AN:
24704
American (AMR)
AF:
0.00135
AC:
23
AN:
17060
Ashkenazi Jewish (ASJ)
AF:
0.00122
AC:
25
AN:
20424
East Asian (EAS)
AF:
0.00732
AC:
202
AN:
27604
South Asian (SAS)
AF:
0.00133
AC:
78
AN:
58572
European-Finnish (FIN)
AF:
0.00888
AC:
377
AN:
42440
Middle Eastern (MID)
AF:
0.00139
AC:
7
AN:
5046
European-Non Finnish (NFE)
AF:
0.00146
AC:
1470
AN:
1008970
Other (OTH)
AF:
0.00256
AC:
130
AN:
50712
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
111
222
332
443
554
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00267
AC:
395
AN:
147916
Hom.:
3
Cov.:
29
AF XY:
0.00295
AC XY:
213
AN XY:
72274
show subpopulations
African (AFR)
AF:
0.00347
AC:
140
AN:
40310
American (AMR)
AF:
0.00147
AC:
22
AN:
15014
Ashkenazi Jewish (ASJ)
AF:
0.000878
AC:
3
AN:
3418
East Asian (EAS)
AF:
0.00637
AC:
31
AN:
4864
South Asian (SAS)
AF:
0.00172
AC:
8
AN:
4656
European-Finnish (FIN)
AF:
0.00670
AC:
66
AN:
9852
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
278
European-Non Finnish (NFE)
AF:
0.00176
AC:
117
AN:
66586
Other (OTH)
AF:
0.00388
AC:
8
AN:
2064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
20
40
60
80
100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00115
Hom.:
2

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ARID1B: BS1, BS2 -

May 13, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 16, 2015
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ARID1B-related disorder Benign:1
Sep 24, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Inborn genetic diseases Benign:1
Apr 05, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Coffin-Siris syndrome 1 Benign:1
May 30, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.7
Mutation Taster
=184/16
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587779747; hg19: chr6-157099981; API